Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Doximity's fiscal 2025 Q2 earnings beat analyst and management expectations despite ongoing macroeconomic uncertainties in ...

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts ...

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to Doximity (DOCS – Research Report). The ...

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

Record-breaking Q2 earnings, soaring revenue, and bullish analyst upgrades make Doximity the healthcare stock to watch ...

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high ...

Pavlo Gonchar / SOPA Images / LightRocket / Getty Images Doximity shares surged Friday morning after the company's second quarter results and outlook for the rest of its fiscal year beat estimates.

In the last three months, 9 analysts have published ratings on Doximity DOCS, offering a diverse range of perspectives from ...

Strategic opportunities in expanding digital healthcare services.

Doximity shares are surging in Thursday's after-hours session after the company reported better-than-expected financial ...